[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU46561B - Postupak za stabilizaciju vodenog rastvora ranitidina - Google Patents

Postupak za stabilizaciju vodenog rastvora ranitidina

Info

Publication number
YU46561B
YU46561B YU224587A YU224587A YU46561B YU 46561 B YU46561 B YU 46561B YU 224587 A YU224587 A YU 224587A YU 224587 A YU224587 A YU 224587A YU 46561 B YU46561 B YU 46561B
Authority
YU
Yugoslavia
Prior art keywords
stabilization
procedure
solution
aqueous
ranitidine solution
Prior art date
Application number
YU224587A
Other languages
English (en)
Other versions
YU224587A (en
Inventor
D.P. Long
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10608930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU46561(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of YU224587A publication Critical patent/YU224587A/xx
Publication of YU46561B publication Critical patent/YU46561B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)

Abstract

POSTUPAK ZA STABILIZACIJU VODENOG RASTVORA RANITIDINA, naznačen time, što se navedenom rastvoru dodaje od oko 2.5 do oko 10 mas/ zapr.% etanola i što se pH tako dobijenog rastvora podešava na oko 6.5 do 7.5. Prijava sadrži još jedan zavisan patentni zahtev.
YU224587A 1986-12-12 1987-12-11 Postupak za stabilizaciju vodenog rastvora ranitidina YU46561B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868629781A GB8629781D0 (en) 1986-12-12 1986-12-12 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
YU224587A YU224587A (en) 1990-10-31
YU46561B true YU46561B (sh) 1993-11-16

Family

ID=10608930

Family Applications (1)

Application Number Title Priority Date Filing Date
YU224587A YU46561B (sh) 1986-12-12 1987-12-11 Postupak za stabilizaciju vodenog rastvora ranitidina

Country Status (23)

Country Link
US (1) US5068249A (sh)
JP (1) JP2590156B2 (sh)
KR (1) KR960008228B1 (sh)
AT (1) AT395373B (sh)
AU (1) AU607451B2 (sh)
BE (1) BE1000624A5 (sh)
CA (1) CA1303993C (sh)
CH (1) CH675207A5 (sh)
CZ (1) CZ281599B6 (sh)
DE (1) DE3742127C2 (sh)
DK (1) DK167842B1 (sh)
FR (1) FR2608921B1 (sh)
GB (2) GB8629781D0 (sh)
HK (1) HK19095A (sh)
IE (1) IE60618B1 (sh)
IL (1) IL84795A0 (sh)
IT (1) IT1211967B (sh)
NL (1) NL194431C (sh)
NZ (1) NZ222879A (sh)
PH (1) PH25390A (sh)
SE (1) SE504333C2 (sh)
YU (1) YU46561B (sh)
ZA (1) ZA879338B (sh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL114464A0 (en) * 1994-07-06 1995-11-27 Farmarc Nederland Bv Inclusion complexes of ranitidine
HU213598B (en) * 1994-10-18 1997-08-28 Ge Lighting Tungsram Rt One-side socketed discharge lamp
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
GB9715423D0 (en) * 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
AU2007275606B9 (en) * 2006-07-21 2013-09-26 Lyne Laboratories, Inc. Liquid compositions of calcium acetate
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735587A1 (de) * 1977-08-06 1979-02-15 Sandoz Ag Stabile loesungen und verfahren zu deren herstellung
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3108753A1 (de) * 1981-03-07 1982-09-16 Degussa Ag, 6000 Frankfurt Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
JPS59101478A (ja) * 1982-11-29 1984-06-12 Sunstar Inc リグスチライドを安定に配合した水系組成物
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer

Also Published As

Publication number Publication date
SE8704952L (sv) 1988-06-13
AU8244487A (en) 1988-06-16
BE1000624A5 (fr) 1989-02-21
GB2198352A (en) 1988-06-15
DK652787D0 (da) 1987-12-11
DK167842B1 (da) 1993-12-27
IT8748698A0 (it) 1987-12-11
KR960008228B1 (ko) 1996-06-21
IL84795A0 (en) 1988-05-31
DK652787A (da) 1988-06-13
FR2608921B1 (fr) 1991-04-12
DE3742127C2 (de) 1997-08-28
NL194431B (nl) 2001-12-03
PH25390A (en) 1991-06-03
CZ281599B6 (cs) 1996-11-13
JPS63215622A (ja) 1988-09-08
CA1303993C (en) 1992-06-23
DE3742127A1 (de) 1988-10-06
US5068249A (en) 1991-11-26
SE8704952D0 (sv) 1987-12-11
SE504333C2 (sv) 1997-01-13
JP2590156B2 (ja) 1997-03-12
FR2608921A1 (fr) 1988-07-01
NZ222879A (en) 1990-08-28
IT1211967B (it) 1989-11-08
ATA327387A (de) 1992-05-15
GB2198352B (en) 1990-11-28
AU607451B2 (en) 1991-03-07
IE60618B1 (en) 1994-07-27
NL8703000A (nl) 1988-07-01
KR880007060A (ko) 1988-08-26
AT395373B (de) 1992-12-10
ZA879338B (en) 1989-02-22
CS403791A3 (en) 1992-08-12
CH675207A5 (sh) 1990-09-14
GB8629781D0 (en) 1987-01-21
GB8728957D0 (en) 1988-01-27
HK19095A (en) 1995-02-17
NL194431C (nl) 2002-04-04
YU224587A (en) 1990-10-31
IE873367L (en) 1988-06-12

Similar Documents

Publication Publication Date Title
YU46561B (sh) Postupak za stabilizaciju vodenog rastvora ranitidina
DE69011766D1 (de) Wässerige Arzneisuspension für im wesentlichen wasserunlösliche Arzneiwirkstoffe.
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
ES2104605T3 (es) Composiciones estables de acido ascorbico.
NO843002L (no) Vandig loesning inneholdende en lipid-loeselig farmasoeytisk substans
ATE52493T1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
HUT35659A (en) Process for producing 4-amino-methylene-chromane- and-chromene-derivatives and pharmaceutical compositions containing them as active agents
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
FR2573652B1 (fr) Composition aqueuse de cromoglycate de sodium
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
ATE12892T1 (de) Arzneimitteltraeger auf der basis von hydroxyalkyl-staerke.
FI902713A0 (fi) Menetelmä stabiilin karboplatiinivesiliuoksen valmistamiseksi
GR1001511B (el) Στεροειδείς συν?έσεις.
DK552985D0 (da) Mercaptanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
BR8504580A (pt) Composto de benzoil-ureia,composicao inseticida,processo para controlar insetos e processo para a preparacao de um composto inseticida
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
FI95777C (fi) Menetelmä 8-N-(dietyyliaminoetyyli)rebekkamysiinin stabiilin vesiliuoksen valmistamiseksi
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
KR880012226A (ko) 외 용 제
NO792126L (no) Karbazolderivater.
ATE30582T1 (de) Ungesaettigte arylalkylammoniumsalze.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.